Possible associations between palliative care conferences and positive outcomes when performing palliative care for patients with end-stage heart failure: a nationwide cross-sectional questionnaire survey.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 15 04 2018
accepted: 14 09 2018
pubmed: 22 9 2018
medline: 19 3 2019
entrez: 22 9 2018
Statut: ppublish

Résumé

Palliative care for end-stage heart failure should be provided by a multidisciplinary team. However, the influence of each occupational category on patients receiving palliative care for end-stage heart failure remains unclear. Thus, this study investigated the relationships between palliative care conferences and positive outcomes of palliative care for end-stage heart failure patients. We sent questionnaires to all cardiology training hospitals authorized by the Japanese Circulation Society (n = 1004); of these, responses from the directors at 554 institutions were analyzed. We divided the responding institutions into two groups according to their implementation of palliative care conferences for patients with end-stage heart failure. The institutions that had held such conferences (n = 223) had a larger number of hospital beds, beds in the cardiovascular department, and patients admitted to the cardiovascular department, compared with institutions that had not held these conferences (n = 321). The usage rates of opioids, non-steroidal anti-inflammatory drugs, and sedatives were significantly higher in institutions that held these conferences. Multivariate analysis revealed that nutritionists and medical social workers had greater involvement in the improvement of mental symptoms and ensuring that patients could stay where they wished, respectively. The presence of palliative care physicians, physical therapists, or pharmacists was associated with multiple positive outcomes. This study indicated that there are possible associations between palliative care conferences and positive outcomes when performing palliative care for patients with end-stage heart failure.

Identifiants

pubmed: 30238352
doi: 10.1007/s00380-018-1261-y
pii: 10.1007/s00380-018-1261-y
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

452-461

Références

Eur J Heart Fail. 2002 Dec;4(6):753-6
pubmed: 12453546
N Engl J Med. 2003 May 15;348(20):2007-18
pubmed: 12748317
Heart. 2003 Sep;89(9):1085-6
pubmed: 12923038
Eur J Cardiovasc Nurs. 2003 Sep;2(3):213-7
pubmed: 14622629
J Am Coll Cardiol. 2004 Aug 18;44(4):810-9
pubmed: 15312864
Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):667-74
pubmed: 16598835
Ann Intern Med. 2008 Jan 15;148(2):147-59
pubmed: 18195339
Eur J Heart Fail. 2009 May;11(5):433-43
pubmed: 19386813
J Am Coll Cardiol. 2009 Jul 28;54(5):386-96
pubmed: 19628112
Circulation. 2009 Dec 22;120(25):2597-606
pubmed: 20026792
Circulation. 2010 Aug 10;122(6):585-96
pubmed: 20660805
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
Eur J Heart Fail. 2011 Sep;13(9):1006-12
pubmed: 21712288
Lancet. 2011 Aug 20;378(9792):713-21
pubmed: 21856485
J Palliat Med. 2012 Jan;15(1):12-5
pubmed: 22216757
Lancet Oncol. 2012 Feb;13(2):e58-68
pubmed: 22300860
Jpn J Clin Oncol. 2012 May;42(5):432-41
pubmed: 22396618
J Altern Complement Med. 2012 May;18(5):480-6
pubmed: 22540970
Circulation. 2013 Oct 15;128(16):e240-327
pubmed: 23741058
Eur J Heart Fail. 2014 Oct;16(10):1142-51
pubmed: 25159126
J Cardiol. 2015 Sep;66(3):181-8
pubmed: 25722045
Support Care Cancer. 2016 Jan;24(1):469-80
pubmed: 26404858
J Natl Compr Canc Netw. 2016 Jan;14(1):82-113
pubmed: 26733557
BMJ. 2016 Apr 14;353:i1010
pubmed: 27079896
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Palliat Med. 2017 Jan;20(1):84-92
pubmed: 27912043
J Clin Oncol. 2017 Jan;35(1):96-112
pubmed: 28034065
J Palliat Med. 2017 Jul;20(7):779-783
pubmed: 28186850
Heart Fail Rev. 2017 Sep;22(5):611-620
pubmed: 28281018
ESC Heart Fail. 2017 May;4(2):81-87
pubmed: 28451443
J Am Coll Cardiol. 2017 Jul 18;70(3):331-341
pubmed: 28705314
J Cardiol. 2018 Feb;71(2):202-211
pubmed: 28844399
Circ J. 2018 Apr 25;82(5):1336-1343
pubmed: 29526984
J Am Coll Cardiol. 1997 Jan;29(1):147-52
pubmed: 8996307

Auteurs

Yuma Kurozumi (Y)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, 2-17-77, Higashinaniwa-cho, Amagasaki, 660-8550, Hyogo, Japan. k_yuma26@yahoo.co.jp.

Shogo Oishi (S)

Department of Cardiology, Himeji Cardiovascular Center, Himeji, Japan.

Yasuo Sugano (Y)

Department of Cardiology, Keiyu Hospital, Yokohama, Japan.
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Akihiro Sakashita (A)

Department of Palliative Medicine, Kobe University School of Medicine, Kobe, Japan.

Norihiko Kotooka (N)

Department of Cardiovascular Medicine, Saga University, Saga, Japan.

Makoto Suzuki (M)

Department of Cardiology, Yokohama Minami Kyosai Hospital, Yokohama, Japan.

Taiki Higo (T)

Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

Dai Yumino (D)

Yumino Heart Clinic, Tokyo, Japan.

Yasuko Takada (Y)

Department of Nursing, National Cerebral and Cardiovascular Center, Suita, Japan.

Seiko Maeda (S)

Department of Nursing, Nagoya Heart Center, Nagoya, Japan.

Saori Yamabe (S)

Department of Nursing, Mitsubishi Kyoto Hospital, Kyoto, Japan.

Koichi Washida (K)

Department of Nursing, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.

Tomonori Takahashi (T)

Department of Pharmacy, Hyogo Cancer Center, Akashi, Japan.

Tomohito Ohtani (T)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Yasushi Sakata (Y)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Yukihito Sato (Y)

Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, 2-17-77, Higashinaniwa-cho, Amagasaki, 660-8550, Hyogo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH